2026 Product Review

NasalCrom (cromolyn sodium): 2026 Review

Mast cell stabilizer: drug-adjacent safety profile; needs dosing discipline.

Content updated Evidence reviewed First published

Literature review current through

NasalCrom
Cromolyn sodium (NasalCrom) is a mast-cell stabilizer that blocks histamine and other mediator release. Because it is poorly absorbed systemically, it is well tolerated and has an excellent overall safety record Expert Intranasal cromolyn sodium is generally less potent than intranasal corticosteroids for moderate-to-severe allergic rhinitis and requires more frequent dosing (typically 3 to 4 times daily). Allergy practice guidelines therefore reserve it for milder symptoms or for patients who prefer to avoid corticosteroids Guideline Intranasal cromolyn sodium has a long-standing favorable safety record and minimal systemic absorption (Ratner 2002); per LactMed, cromolyn is generally considered acceptable during pregnancy and lactation when symptoms warrant pharmacotherapy, especially as a non-steroid adjunct Expert NasalCrom (cromolyn sodium) is dosed at 1 spray per nostril 3 to 4 times daily (every 4 to 6 hours), with up to 6 doses per day if needed; consistent daily use is required because the effect builds over 1 to 2 weeks Expert

Best fit: mild allergic rhinitis, pregnancy or breastfeeding adjunct, or patients who prefer a non-steroid option. Nasonex or Rhinocort (if pregnant) are more potent picks but also make great adjunct therapy to Nasalcrom. Technique is especially important given the 4–6× daily cadence; see the spray technique guide.

Context & alternatives

For eligible patients 13+ with multi-symptom, year-round, or failed-OTC rhinitis (not pregnant or breastfeeding), Allermi is our #1 overall pick: a compounded telehealth Rx personalized by a board-certified allergist. NasalCrom remains the most conservative non-steroid adjunct when pregnancy or breastfeeding rule Allermi out. Not sure if you qualify for Allermi (post-partum, for example)? Check eligibility in 60 seconds.

References

  1. DailyMed: NasalCrom SPL · FDA DailyMed https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8f6e39b-5c66-4b9a-8f58-11f75d6a8a1c

This page is grounded in primary literature, reviewed by the BestAllergyNasalSprays editorial team. See our editorial methodology and the public claims library.